 Arthritis, Rheumatoid
"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Descriptor ID |
D001172
|
| MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 9 | 0 | 9 | | 1997 | 7 | 2 | 9 | | 1998 | 8 | 3 | 11 | | 1999 | 10 | 1 | 11 | | 2000 | 7 | 2 | 9 | | 2001 | 16 | 0 | 16 | | 2002 | 16 | 3 | 19 | | 2003 | 9 | 2 | 11 | | 2004 | 13 | 0 | 13 | | 2005 | 10 | 5 | 15 | | 2006 | 18 | 3 | 21 | | 2007 | 8 | 2 | 10 | | 2008 | 6 | 1 | 7 | | 2009 | 23 | 0 | 23 | | 2010 | 33 | 2 | 35 | | 2011 | 16 | 2 | 18 | | 2012 | 18 | 0 | 18 | | 2013 | 37 | 3 | 40 | | 2014 | 28 | 0 | 28 | | 2015 | 26 | 1 | 27 | | 2016 | 31 | 3 | 34 | | 2017 | 23 | 1 | 24 | | 2018 | 27 | 0 | 27 | | 2019 | 28 | 4 | 32 | | 2020 | 29 | 2 | 31 | | 2021 | 26 | 3 | 29 | | 2022 | 30 | 0 | 30 | | 2023 | 31 | 0 | 31 | | 2024 | 29 | 5 | 34 | | 2025 | 22 | 1 | 23 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
Qureshi S, Adas M, Cope PJ, Mahfouz H, Bechman K, Deane KD, El-Gabalawy H, Emery P, Finckh A, Gilbert BTP, Holers VM, Isaacs JD, Kastbom A, Mankia K, Mikuls TR, Pratt AG, Rech J, Russell MD, Schett G, Trouw LA, Turesson C, Beers-Tas MHV, van der Helm-van Mil AHM, van Schaardenburg D, van Steenbergen HW, Toes REM, Cope AP, Galloway J, Norton S. Autoantibodies as predictors of progression to rheumatoid arthritis: a systematic review and meta-analysis. RMD Open. 2026 Feb 11; 12(1).
-
Shi J, Yu C, Ke D, Yuan X, Pang Y, Wu Y, Wang T, Stultz R, Liu X, Tian X, Li M, Wang Q, Demoruelle MK, Solomon JJ, Lood C. Systemic neutrophil activation and N-formyl methionine-formyl peptide receptor-1 signaling define inflammatory endotypes in rheumatoid arthritis-associated lung involvement. J Intern Med. 2025 Dec; 298(6):656-669.
-
McDermott GC, Gill R, Byrne S, Gagne S, Wang X, Paudel ML, Kowalski E, Qian G, Bade K, Mueller K, Saavedra A, Vanni KMM, Getachew LS, Bolden C, O'Keeffe LA, Davis NA, Puri A, Mahajan T, Mulcaire-Jones E, Kortam N, Juge PA, Doyle TJ, Dellaripa PF, Wallace ZS, San Jose Estepar R, Washko GR, Bolster MB, Deane KD, Khanna D, England BR, Sparks JA. Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA. Lancet Rheumatol. 2025 Dec; 7(12):e851-e863.
-
He Z, Glass MC, Venkatesan P, Feser ML, Lazaro L, Okada LY, Tran NTT, He YD, Zaim SR, Bennett CE, Ravisankar P, Dornisch EM, Ferrannini AC, Arishi NA, Asamoah AG, Barzideh S, Becker LA, Bemis EA, Buckner JH, Collora CE, Criley MAL, Demoruelle MK, Fleischer CL, Garber J, Genge PC, Gong Q, Graybuck LT, Gustafson CE, Hattel BC, Hernandez V, Heubeck AT, Kawelo EK, Krishnan U, Kuan EL, Kuhn KA, LaFrance CM, Lee KJ, Li R, Lord C, Mettey RR, Moss L, Musgrove B, Nguyen KH, Ochoa A, Parthasarathy V, Pebworth MP, Pedrick C, Peng T, Phalen CG, Reading J, Roll CR, Seifert JA, Siedschlag MD, Speake C, Striebich CC, Stuckey TJ, Swanson EG, Takada H, Thai T, Thomson ZJ, Trieu N, Tsaltskan V, Wang W, Weiss MDA, Westermann A, Zhang F, Boyle DL, Goldrath AW, Bumol TF, Li XJ, Holers VM, Skene PJ, Savage AK, Firestein GS, Deane KD, Torgerson TR, Gillespie MA. Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation. Sci Transl Med. 2025 Sep 24; 17(817):eadt7214.
-
Li J, Kuhn KA. Microbial threads in the tapestry of rheumatoid arthritis. J Clin Invest. 2025 Sep 16; 135(18).
-
Zhu H, Lee W, Miller EY, Seifert J, Clauw A, Moreland LW, Neu CP. Displacement-encoded MRI reveals biomechanical stiffening in rheumatoid arthritis wrists: a case control study. Sci Rep. 2025 Sep 02; 15(1):32351.
-
Smolen J, Sands BE, Jackson DJ, Wechsler ME, Jackson DJ, Akuthota P, Lega Hoyte FC, Pavord I, Katial RK, Rogers L. Asthma remission in the context of other immune-mediated diseases. J Allergy Clin Immunol. 2025 Sep; 156(3S):S1-S6.
-
Wallace BI, England BR, Baker JF, George MD, Sauer BC, Rojas J, Roul P, Wysham KD, Brubeck H, Smith I, Caplan L, Monach PA, Kerr GS, Kunkel G, Braaten T, Mikuls TR, Cannon GW. Agreement of Administrative Pharmacy Dispensing With Self-Reported Use of Oral Prednisone in US Veterans With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2025 Nov; 77(11):1350-1358.
-
Kuhn KA, Yomogida K, Knoop K, Wu HJ, Zaiss MM. More than a leaky gut: how gut priming shapes arthritis. Nat Rev Rheumatol. 2025 Sep; 21(9):513-525.
-
Matson SM, Kim GHJ, Humphries SM, Roth MD, Goldin J, Tashkin DP, Leng M, England BR, Lee JS, Volkmann ER. Impact of quantitative radiological features of interstitial lung disease on immunomodulatory treatment response in three autoimmune interstitial lung disease cohorts. Thorax. 2025 07 15; 80(8):540-546.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|